Oric Pharmaceuticals Inc
NASDAQ:ORIC
Cash Flow Statement
Cash Flow Statement
Oric Pharmaceuticals Inc
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||
| Net Income |
(27)
|
(30)
|
(35)
|
(54)
|
(74)
|
(81)
|
(91)
|
(84)
|
(79)
|
(85)
|
(85)
|
(91)
|
(89)
|
(90)
|
(93)
|
(93)
|
(101)
|
(102)
|
(111)
|
(120)
|
(128)
|
(133)
|
(137)
|
(135)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
2
|
3
|
5
|
5
|
7
|
9
|
11
|
13
|
14
|
15
|
15
|
14
|
14
|
14
|
14
|
15
|
17
|
18
|
19
|
20
|
22
|
23
|
24
|
|
| Other Non-Cash Items |
1
|
1
|
3
|
17
|
25
|
28
|
30
|
19
|
14
|
15
|
15
|
15
|
13
|
12
|
11
|
10
|
9
|
9
|
9
|
10
|
12
|
15
|
18
|
20
|
|
| Change in Working Capital |
1
|
1
|
1
|
1
|
2
|
0
|
2
|
3
|
4
|
2
|
(1)
|
(1)
|
(0)
|
4
|
4
|
6
|
5
|
(4)
|
1
|
(0)
|
2
|
2
|
(2)
|
(3)
|
|
| Cash from Operating Activities |
(24)
N/A
|
(26)
-12%
|
(30)
-16%
|
(35)
-14%
|
(45)
-31%
|
(52)
-15%
|
(59)
-13%
|
(61)
-4%
|
(60)
+3%
|
(67)
-13%
|
(69)
-2%
|
(76)
-10%
|
(75)
+1%
|
(73)
+3%
|
(76)
-5%
|
(77)
0%
|
(86)
-12%
|
(95)
-11%
|
(100)
-5%
|
(109)
-9%
|
(113)
-3%
|
(115)
-2%
|
(120)
-4%
|
(116)
+3%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
(124)
|
(215)
|
(175)
|
(92)
|
68
|
159
|
29
|
(99)
|
(135)
|
(107)
|
(4)
|
22
|
(35)
|
(43)
|
(117)
|
(80)
|
1
|
23
|
108
|
12
|
(121)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+38%
|
(0)
+40%
|
(125)
-42 921%
|
(216)
-73%
|
(176)
+19%
|
(93)
+47%
|
67
N/A
|
158
+137%
|
27
-83%
|
(101)
N/A
|
(137)
-35%
|
(109)
+20%
|
(6)
+95%
|
21
N/A
|
(36)
N/A
|
(43)
-20%
|
(118)
-172%
|
(81)
+32%
|
(0)
+100%
|
22
N/A
|
106
+381%
|
12
-89%
|
(122)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||
| Net Issuance of Common Stock |
71
|
56
|
144
|
138
|
272
|
272
|
134
|
184
|
51
|
51
|
51
|
1
|
26
|
26
|
110
|
110
|
86
|
211
|
127
|
127
|
127
|
2
|
135
|
246
|
|
| Other |
(0)
|
(2)
|
(13)
|
(13)
|
(21)
|
0
|
(9)
|
(10)
|
(2)
|
0
|
(2)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(2)
|
|
| Cash from Financing Activities |
71
N/A
|
54
-24%
|
131
+143%
|
125
-5%
|
251
+100%
|
252
+1%
|
125
-50%
|
174
+39%
|
49
-72%
|
49
N/A
|
50
+1%
|
1
-98%
|
25
+1 935%
|
25
0%
|
110
+336%
|
110
+0%
|
86
-22%
|
211
+146%
|
126
-40%
|
126
0%
|
127
+0%
|
2
-99%
|
135
+8 726%
|
244
+81%
|
|
| Change in Cash | |||||||||||||||||||||||||
| Net Change in Cash |
47
N/A
|
27
-42%
|
100
+269%
|
(34)
N/A
|
(11)
+69%
|
25
N/A
|
(27)
N/A
|
180
N/A
|
148
-18%
|
9
-94%
|
(121)
N/A
|
(212)
-76%
|
(159)
+25%
|
(54)
+66%
|
55
N/A
|
(3)
N/A
|
(43)
-1 446%
|
(3)
+94%
|
(54)
-1 983%
|
17
N/A
|
36
+110%
|
(7)
N/A
|
26
N/A
|
6
-76%
|
|
| Free Cash Flow | |||||||||||||||||||||||||
| Free Cash Flow |
(24)
N/A
|
(27)
-11%
|
(31)
-14%
|
(35)
-13%
|
(46)
-32%
|
(53)
-15%
|
(59)
-12%
|
(62)
-5%
|
(60)
+3%
|
(69)
-14%
|
(71)
-3%
|
(78)
-10%
|
(77)
+1%
|
(75)
+3%
|
(78)
-4%
|
(78)
N/A
|
(87)
-11%
|
(96)
-11%
|
(101)
-5%
|
(110)
-10%
|
(114)
-3%
|
(116)
-2%
|
(121)
-4%
|
(117)
+4%
|
|